Distinguish thin eyelid skin, descriptive morphology and histological tumour spread. When malignancy is suspected, establish the diagnosis and appropriate margin assessment before planning definitive reconstruction.
Terminology and draft status
Terminology review is not complete. Actual inspected WHO UMD entries are recorded in terminology.md; they do not approve the entire translation.
01Locate the layers of thin eyelid skin
Eyelid skin is very thin. The epidermis provides the outer barrier, while the dermis contains supporting connective tissue and skin appendages; distinguish these layers from deeper orbital compartments. 9
The original five-layer model needs correction for thin eyelid skin: stratum basale, spinosum, granulosum and corneum remain the principal layers. Stratum lucidum is a clear transitional layer of thick glabrous skin, especially palms and soles. 1
The stratum basale contains basal cells and melanocytes. Desmosomes connect cells in the multilayered stratum spinosum; the stratum granulosum contains keratohyalin granules. 9
The cornified layer contains dead, anucleate corneocytes. Keratinization involves nuclear loss; the original 65% keratin figure was not independently substantiated here and is not adopted as a fixed composition of eyelid skin. 9
The thin dermis contains hair follicles, sebaceous glands (Glandulae sebaceae) and sweat glands, fibroblasts, and blood and lymphatic vessels. Assigning a structure to dermis, subcutis or orbit is more useful clinically than a blanket statement of “no fat”. 9
Fat in an unspecified eyelid region does not diagnose orbital proptosis. The original inference remains unsupported; orbital fat compartments and actual forward displacement of the globe require separate assessment. 9
The upper eyelid generally has more lashes than the lower eyelid. The export states over 75 upper lashes but also contains the uninterpretable sequence “fünf in dreißig, fünfundzwanzig, und fünfundzwanzig unter zwanzig”; no corrected reference count is reconstructed from it. 9
02Describe the skin lesion first
The terms in the table first describe form, content and elevation. They establish neither cause nor benign or malignant status; also document size, colour, border and course. 2
Herpes zoster vesicles can become pustular during their course. Pus as content does not establish a bacterial cause; painful eyelid blisters require appropriate assessment because the eye may be involved. 9
| Term | Description | Comments |
|---|---|---|
| Vesicle | Small fluid-filled blister. | — |
| Bulla | Large fluid-filled blister. | — |
| Pustule | Circumscribed pus-containing lesion. | Herpes zoster vesicles can become pustular. |
| Papule | Small solid elevated lesion. | — |
| Plaque | Broad palpable lesion, usually elevated. | Original: flat and elevated; distinguish extent from height. |
03Distinguish proliferation, atypia and invasion
Hyperplasia means increased cell number and can be reactive. The term alone is neither a confirmed benign diagnosis nor the start of inevitable cancer progression. 9
Dysplasia describes cellular atypia and disordered tissue architecture. Findings include an increased nuclear-to-cytoplasmic ratio, hyperchromasia and loss of orderly layering. 9
Carcinoma in situ, or intraepithelial carcinoma, involves marked atypical epithelial changes with an intact basement membrane. Bowen disease is the corresponding term for cutaneous squamous cell carcinoma in situ; it does not denote every in-situ neoplasm. 4
Bowen disease shows full-thickness atypical keratinocyte proliferation. Actinic keratosis and Bowen disease should therefore not be equated merely because the words “precancerous” or “in situ” are used. 4
Invasive carcinoma breaches the basement membrane and enters underlying tissue such as the dermis. The sequence hyperplasia–dysplasia–in-situ carcinoma–invasion is a teaching model, not the inevitable course of every increase in cell number. 9
04State actinic keratosis risk with its denominator
Actinic keratosis (AK) is a UV-associated keratinocytic lesion that can progress to squamous cell carcinoma. The original 75% figure is unsupported as a general transformation risk. 3
The Werner systematic review included 24 studies. Its accessed abstract reports 0–0.075% progression per lesion-year, up to 0.53% per lesion in those with previous nonmelanoma skin cancer; limited, heterogeneous data do not support a universal personal prediction. 3
The German S3 guideline Version 2.0 describes a much broader published range of 0.03–20% per lesion-year. These estimates from different populations and methods are not a new pooled estimate and should not be averaged with the review. 4
Decisions depend on clinical findings, immunosuppression, cumulative UV exposure, lesion number, comorbidity, life expectancy and patient preference. Even early lesions can progress; a low study rate does not justify universally waiting without treatment. 4
05Assess change and warning signs together
A lesion unchanged since birth or for 20 years is less concerning than a new lesion growing over months. Duration alone does not prove benignity; ask specifically about new changes in shape or colour. 5
The table contrasts clinical clues, not definitive diagnostic criteria. Lash loss, ulceration and infiltration increase concern; ask also about previous skin cancers and procedures. 5
Uncertain or suspicious findings require histological assessment. Eyelid location, tissue preservation and later reconstruction favour appropriate ophthalmic, dermatological or oculoplastic planning. 8
The LUI study examined 199 biopsied lesions:161 benign and 38 malignant, the latter 34 basal cell and 4 squamous cell carcinomas. All three signs together had 21% sensitivity and 99% specificity; their absence therefore does not exclude a tumour. 5
Features were assessed on two-dimensional photographs from a selected referral population. The study contained no malignant melanoma; its additional brief before-and-after student exercise does not establish long-term clinical effectiveness. 5
| Feature | More reassuring clue | Suspicious clue |
|---|---|---|
| Symmetry | Symmetric | Asymmetric |
| Borders | Regular and well defined | Irregular or ill defined |
| Surface | Smooth and intact | Ulcerated |
06Plan diagnostic biopsy separately from definitive excision
Excisional biopsy removes the entire lesion for diagnosis. Incisional biopsy samples a representative part, for example when a large or uncertain lesion would leave a substantial defect if removed completely at once. 6
The original margin of approximately 4 mm is not a universal rule for every suspicious eyelid lesion. Distinguish diagnostic sampling from definitive tumour resection; tumour type, risk, anatomical function and histological margin assessment guide planning. 6
An intraoperative frozen section can assess sampled margins. Positive margins may require targeted further excision; “clear margins” refers to the examined margins and does not guarantee every unexamined surface. 9
For suspected melanoma, the S3 guideline recommends complete diagnostic excision with a small margin where feasible. It permits partial biopsy in selected circumstances, such as large flat facial lesions; the site and partial nature of the sample must be communicated to pathology. 6
The meta-analysis of 5 studies and 3249 patients found a recurrence risk ratio of 1.27 (95%CI 0.97–1.67) and melanoma-related death ratio of 1.50 (0.98–2.30) for partial versus excisional biopsy. Predominantly retrospective data, potential selection and confidence intervals allowing meaningful harm establish neither equivalence nor a universal claim of induced metastasis. 7
A partial sample can miss the maximum Breslow tumour thickness or other crucial components. Distinguish this diagnostic limitation from a claim of tumour seeding; coordinate sampling and definitive surgery individually. 6
Appropriate histological margin assessment can preserve healthy tissue and guide reconstruction for poorly defined eyelid tumours. Selected frozen sections do not automatically constitute complete three-dimensional margin control or Mohs surgery; specify the method and its limits. 4
What are the main learning points of this eyelid lecture?
Distinguish thin eyelid skin, descriptive morphology and histological tumour spread. When malignancy is suspected, establish the diagnosis and appropriate margin assessment before planning definitive reconstruction.
Which findings require urgent assessment?
Seek immediate help for sudden vision loss, severe pain or a new visual field defect. A growing, ulcerated or infiltrating eyelid lesion needs prompt specialist assessment.
References and access status
- 1Leeds histology: thick and thin skin
Clinical teaching text on thin/thick skin read; images not visually appraised.
- 2ILDS revised glossary for cutaneous lesions (2016)
Actual PDF Table1 definitions and discussion of variable terminology read; consensus terminology, not diagnostic accuracy evidence.
- 3Werner et al. The natural history of actinic keratosis: a systematic review
Complete NCBI PubMed abstract read; main report, protocol and underlying studies unread.
- 4S3 AK / cutaneous SCC, Version2.0, December2022
Actual selected sections4.3,5.2 and7.2–7.4 read, including printed pp42, 62, 181–184; no whole-guideline or independent underlying-study appraisal.
- 5Leung et al. LUI triage key (2015)
Actual main introduction, methods, results, Tables1–2 and discussion/limitations read; photographs not visually inspected and cited external studies unread.
- 6S3 Melanoma, Version3.3, July2020
Actual section4.3 recommendation4.7 and explanatory text printed p43 read. Historical version linked by the official catalog; not an asserted new2026 guideline or whole-report appraisal.
- 7Moscarella et al. Partial versus excisional biopsy of melanoma
Complete NCBI PubMed abstract read; main report, protocol and supplements unread. Predominantly retrospective evidence.
- 8Clinical evaluation of eyelid tumours (2023)
Complete actual NCBI bilingual abstract read; narrative review, main report unread.
- 9Original exported Kanski made easy – Lid1 teaching text
Complete local original export read; video, transcript, channel attribution and Kanski edition not independently verified. Not independent support for disputed claims.
Original lecture link
- Kanski made easy – Lid1
Exported link; recording, transcript and attribution not independently checked.
For patients
An eyelid change can arise from skin, glands or other tissues. Appearance and course provide clues; a tissue sample can establish the diagnosis when there is concern.
This information does not replace personal examination. The type and extent of biopsy and subsequent care depend on individual findings.
Seek immediate help for sudden vision loss, severe pain or a new visual field defect. Arrange prompt assessment of growing, bleeding or nonhealing eyelid lesions.
Seek immediate help for sudden vision loss, severe pain or a new visual field defect. A growing, ulcerated or infiltrating eyelid lesion needs prompt specialist assessment.